Gene therapy that restores vision in dogs may help humans, too
(Michigan State University) A Michigan State University veterinary ophthalmologist has modified a gene therapy that reverses blindness in dogs that have a certain form of a disease known as progressive retinal atrophy, or PRA, and is now looking to advance the treatment for human use. Simon Petersen-Jones in the College of Veterinary Medicine has received a five-year, $8.2 million grant from the National Institutes of Health to further the therapy for people who have a type of retinitis pigmentosa. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2018 Category: International Medicine & Public Health Source Type: news

Study provides further insight into how Ebola affects the eye
(University of Liverpool) A new study, conducted by the researchers from the University of Liverpool, published in JAMA Ophthalmology identifies the specific characteristics of Ebola retinal lesions, which provide further clues as to how the virus travels to the retina and causes damage. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 15, 2018 Category: Infectious Diseases Source Type: news

Acceptability of the Predicting Abusive Head Trauma (PredAHT) clinical prediction tool: a qualitative study with child protection professionals - Cowley LE, Maguire S, Farewell DM, Quinn-Scoggins HD, Flynn MO, Kemp AM.
The validated Predicting Abusive Head Trauma (PredAHT) tool estimates the probability of abusive head trauma (AHT) based on combinations of six clinical features: head/neck bruising; apnea; seizures; rib/long-bone fractures; retinal hemorrhages. We aimed t... (Source: SafetyLit)
Source: SafetyLit - May 14, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Genome surgery for eye disease moves closer to reality
(American Academy of Ophthalmology) Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: How to manage thin skin
As a person ages, their skin naturally becomes thinner, less elastic, or papery. While there is no specific way to treat thin skin or to thicken the skin, a person can prevent skin from getting thinner by using retinol creams and avoiding risk factors such as smoking, drinking alcohol, and spending time in the sun. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 10, 2018 Category: Consumer Health News Tags: Dermatology Source Type: news

Retinal Changes on OCT Angiography May Flag Early Alzheimer's Retinal Changes on OCT Angiography May Flag Early Alzheimer's
Microvascular changes in the eye detected by noninvasive optical coherence tomography angiography may herald preclinical Alzheimer's disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Second Sight Medical raises $10m
Second Sight Medical (NSDQ:EYES) said today it inked a stock purchase agreement worth approximately $10 million with businesses owned by board chair Gregg Williams. In the purchase agreement, the Los Angeles-based company said it sold approximately 6.8 million shares of common stock at $1.48 per share. “As chairman of our board, Gregg has provided valuable guidance to Second Sight’s leadership team and we sincerely appreciate his ongoing confidence in the strategy and future of our business. I look forward to updating shareholders during the May 10 earnings call regarding our progress with the Orion f...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Second Sight Source Type: news

Vitamin A deficiency puts 140 million children at risk of illness and death – UNICEF
More than 140 million children are at greater risk of illness, hearing loss, blindness and even death globally if urgent action is not taken to provide them with life-saving vitamin A supplements, the United Nations Children ’s Fund (UNICEF) has warned. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 2, 2018 Category: International Medicine & Public Health Source Type: news

J & J gets in on $15m Series C for NeuroVision Imaging
NeuroVision Imaging said today it raised $15 million in a Series C round joined by Johnson & Johnson‘s (NYSE:JNJ) Innovation arm, with funds slated to support validation and approval of the company’s eye imaging system. The round was led by Wildcat Capital Management and joined by J&J Innovation, Nikon-SBI Innovation Fund, Whittier Ventures and VSP Global, the Sacramento, Calif.-based company said. “NeuroVision’s groundbreaking technology provides for the important possibility of detecting neurodegenerative diseases earlier through the discovery of symptoms in the eyes. In the end, this is a...
Source: Mass Device - May 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Optical/Ophthalmic johnsonandjohnson NeuroVision Source Type: news

NeuroVision announces a $15 million Series C financing with a first close of $11.2 million
(Public Relations Pacific LLC) NeuroVision Imaging Inc. has announced a Series C financing round of $15 million with an initial close of $11.2 million. The round is led by Wildcat Capital Management with funding from several new investment groups. The financing provides support for NeuroVision as it seeks validation and regulatory approval for its breakthrough, low-cost, noninvasive, eye imaging system for measuring retinal autofluorescence that can detect amyloid beta (Aβ) plaque in the eye. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 2, 2018 Category: Biology Source Type: news

Strategy prevents blindness in mice with retinal degeneration
(Duke University Medical Center) New research published in Nature Communications outlines a strategy that in mouse models significantly delayed the onset of blindness from inherited retinal degeneration such as retinitis pigmentosa. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2018 Category: International Medicine & Public Health Source Type: news

UMKC lands $1.97M grant for glaucoma treatment
Researchers at the University of Missouri-Kansas City School of Medicine landed $1.937 million to develop a way to treat patients with end-stage glaucoma. The five-year grant from the National Institutes of Health will support principal investigator Karl Kador's research on ways to restore vision to patients with glaucoma and other eye disorders. Kador, an assistant professor of ophthalmology and biomedical sciences, studies disease and injuries that lead to the death of retinal ganglion cells,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Pure and Potent Human Primary Retinal Pigment Endothelial Cells (HRPES)
Culture ReadyNeuromics is a recognized leader in providing researchers 21-CFR CompliantPrimary Human Cells.Here we feature our newRetinal Pigment Epithelial Cell (HRPES). These hard to find cells are reasonably priced and culture ready,HRPES in CultureCells are provided at passage 3. HRPEs growth medium (contains 10% serum and growth supplements, Alpha-33) is recommended for cell culture and these cells have a minimum average population doubling capacity of 8 when cultured following the detailedprotocol. (Source: Neuromics)
Source: Neuromics - April 26, 2018 Category: Neuroscience Tags: cell culturing protocol culturing human retinal pigment epithelial cells Source Type: news

Medical News Today: Could this vitamin A derivative cure liver cancer?
Researchers reveal how a compound called acyclic retinoid, which is a synthetic form of vitamin A, can target and destroy liver cancer stem cells. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 25, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Retinal Abnormalities Predictor of Some Types of Stroke
(MedPage Today) -- Retinal imaging may offer noninvasive tool to determine pathogenesis of cerebral small vessel disease (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 24, 2018 Category: Cardiology Source Type: news

Eyes Might ID Preclinical Alzheimer's
(MedPage Today) -- Presymptomatic patients show foveal thinning, retinal changes (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 24, 2018 Category: Psychiatry Source Type: news

Vitamin A derivative selectively kills liver cancer stem cells
(RIKEN) Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer. Now, in research published in Proceedings of the National Academy of Sciences, scientists have discovered that the compound targets one class of cancer stem cells, preventing them from giving rise to new tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2018 Category: Cancer & Oncology Source Type: news

Teenagers' eyes reveals their future heart-disease risk
Researchers from The Westmead Institute for Medical Research, Australia, found that for every one point increase in a person's health quality-of-life, their retinal vessels narrow by  0.00005mm, (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2018 Category: Consumer Health News Source Type: news

Spark Therapeutics' ground-breaking gene therapy now being administered at select hospitals
Spark's first product, Luxturna, was approved by the FDA in December to treat an inherited retinal disorder that leads to blindness if untreated. The first patients have been treated with the gene therapy, which is now available at a select group of medical centers. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 20, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

New research: Eyes of adolescents could reveal risk of cardiovascular disease
(Westmead Institute for Medical Research) New research has found that poorer well-being or 'health-related quality of life' (HRQoL) in adolescence could be an indicator of future cardiovascular disease risk. Researchers at The Westmead Institute for Medical Research found that adolescents with poorer scores in the social and mental well-being domains of HRQoL have structural changes in their retinal blood vessels that could be associated with an increased risk of cardiovascular disease in later life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2018 Category: International Medicine & Public Health Source Type: news

With Antimalarials in Lupus, Watch for Retinal Toxicity
(MedPage Today) -- Following guidelines will minimize risk, specialist says (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - April 17, 2018 Category: Rheumatology Source Type: news

Stem-cell-based Implant Feasible in Macular Degeneration Stem-cell-based Implant Feasible in Macular Degeneration
A bioengineered implant of human embryonic stem-cell-derived retinal pigment epithelium (RPE) may be of benefit in advanced dry age-related macular degeneration (AMD), according to preliminary research.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 13, 2018 Category: Transplant Surgery Tags: Ophthalmology News Source Type: news

Non-invasive detection of unique molecular signatures in laser-induced retinal injuries - Naiman MI, Bouhenni R, Ansari RR, Dunmire J, Liu Y, Rafiq Q, Edward D.
Unintentional laser exposure is an increasing concern in many operational environments. Determining whether a laser exposure event caused a retinal injury currently requires medical expertise and specialized equipment that are not always readily available.... (Source: SafetyLit)
Source: SafetyLit - April 12, 2018 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

FDA approves first AI-powered device to detect diabetic retinopathy
The FDA today approved the first medical device to harness artificial intelligence for the detection of diabetic retinopathy in adults who have diabetes. IDx’s software uses an algorithm to analyze images of the eye taken with a retinal camera. A doctor uploads the images to a cloud server with IDx-DR software, which then tells the physician if it detects more than mild diabetic retinopathy. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves first AI-powered device to detect diabetic retinopathy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - April 11, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Software / IT idx Source Type: news

Patient Support Program Triumphs
A patient support program offering around the clock assistance to glioblastoma multiforme (GBM) patients undergoing an innovative therapy has been named the Most Valuable Patient Initiative award at eyeforpharma ’s annual awards ceremony in Philadelphia.   Reflecting on the win, Novocure said: “We are humbled to have helped so many patients and to be recognised for it by our peers who have made careers out of trying to help patients in the most need. The eyeforpharma awards are helping pharma to focus on its core constituent — the patient.”  In naming the PSP as the winner of the 2018...
Source: EyeForPharma - April 10, 2018 Category: Pharmaceuticals Authors: Adam Chapman Source Type: news

Medtronic taps Harvard cardiologist Mauri for clinical research VP | Personnel Moves – April 10, 2018
Medtronic (NYSE:MDT) said last week it tapped Harvard Medical School professor and cardiologist Dr. Laura Mauri as its new vice president of global clinical research and analytics. In the new position, Dr. Mauri will direct dynamic global clinical research strategies as well as the development of novel analytical and data science solutions as the Fridley, Minn.-baesd company looks to address “expanding global requirements for clinical evidence for our products.” Dr. Mauri is slated to assume the role on September 1, Medtronic said. Prior to joining Medtronic, Dr. Mauri served as chief scientific officer of...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Avedro Inc. Clarify Medical GE Harvard Henry Schein Medical Mauna Kea Technologies Medtronic milestonescientific Nemaura Medical Omnicell Inc. personnel-moves Second Sight Stryker Source Type: news

Medical News Today: Four causes of an orange tongue
Looking in a mirror and seeing that the tongue has turned orange may be alarming, especially when a person has eaten nothing containing food coloring recently. In this article, learn what causes an orange tongue, including infections, medications, and beta carotene. We also describe what other colors may indicate. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 6, 2018 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Composite Subretinal Implants May Lessen Vision Loss From AMD
THURSDAY, April 5, 2018 -- A composite implant, termed the California Project to Cure Blindness-Retinal Pigment Epithelium 1 (CPCB-RPE1), which consists of a polarized monolayer of human embryonic stem cell-derived RPE (hESC-RPE) on an ultrathin... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2018 Category: Pharmaceuticals Source Type: news

This retinal implant may one day cure blindness caused by macular degeneration
For many of the 10 million Americans who are losing their vision to a thievish eye condition with no treatment, help may be on its way.In a very early clinical trial, researchers have implanted a stem cell “patch” to repair failing retinal cells in four patients with a condition called “dry” macular... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 5, 2018 Category: Science Authors: Melissa Healy Source Type: news

Researchers test stem cell-based retinal implant for common cause of vision loss
(University of Southern California - Health Sciences) Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for use in people with advanced dry age-related macular degeneration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 4, 2018 Category: International Medicine & Public Health Source Type: news

Older Americans Are ‘ Hooked ’ on Vitamins
Sixty-eight percent of those 65 and older take vitamin supplements. Much of what we once believed about the benefits is wrong. (Source: NYT Health)
Source: NYT Health - April 3, 2018 Category: Consumer Health News Authors: LIZ SZABO, KAISER HEALTH NEWS Tags: Vitamins Preventive Medicine Dietary Supplements and Herbal Remedies Diet and Nutrition Prostate Cancer Heart Hazardous and Toxic Substances Vegetables Folic Acid Vitamin E Vitamin D Calcium Omega-3 Fatty Acids Beta Carotene Source Type: news

Vitamin A Appears Helpful in Pediatric Retinitis Pigmentosa
MONDAY, April 2, 2018 -- For children with retinitis pigmentosa, vitamin A supplementation is associated with slower loss of cone electroretinogram amplitude, according to a study published online March 29 in JAMA Ophthalmology. Eliot L. Berson,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 2, 2018 Category: Pharmaceuticals Source Type: news

Vitamin A Slows Progression of Retinitis Pigmentosa in Kids
(MedPage Today) -- Now the question is how (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - March 30, 2018 Category: Pediatrics Source Type: news

Newly Discovered Antibiotic Drug Offers Hope For Treating MRSA
A new class of antibiotics, chemically related to vitamin A have shown early promise by killing MRSA in mice. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 28, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Second Sight Medical taps Blake as CFO | Personnel Moves – March 27, 2018
Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with Volcano during its $1.2 billion sale to Royal Philips (NYSE:PHG) in 2015, Second Sight added. “We are delighted to welcome John to the Second Sight team. John’s financial acumen, track record of results and broad life sciences industry experience wi...
Source: Mass Device - March 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News acessahealth Bayer Boston Scientific collagenmatrix Dentsply Sirona innovatusimaging integralifesciences NovaBone Nuvasive Orthovita Inc. Paradigm Spine royalphilips Second Sight Smith & Nephew Trice M Source Type: news

Immunotherapy Drugs Causing Vision Issues
The U.S. Food and Drug Administration (FDA) is investigating the potential for three immunotherapy drugs to cause retinal detachment and vision loss. The FDA will consider adding eye toxicities to the warning labels for pembrolizumab (Keytruda), nivolumab (Opdivo) and ipilimumab (Yervoy), which have shown promise in clinical trials involving malignant mesothelioma. All three have already been approved by the FDA for use with metastatic melanoma. Keytruda and Opdivo also have approval for head and neck cancers, colorectal cancers and certain non-small cell lung cancers. The FDA used its Adverse Event Reporting System (FAERS...
Source: Asbestos and Mesothelioma News - March 27, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Weekend Recipe: Wholesome Carrot, Apple and Oatmeal Muffins
If you crave a quick and healthy breakfast or snack on the run, then these wholesome muffins hit the spot in every way. They are packed with fiber and quality ingredients and are the perfect portable meal if you need some quick nourishment. I love to make them when I know I’ve got a busy week in front of me. They last for about five days when stored in the fridge, and marry perfectly with an almond milk latte. The addition of a generous amount of grated carrot and apple helps to keep them delicate and moist, while the walnuts add a crunch and a boost of omega-3s. You don’t need to fuss when making these muffin...
Source: TIME: Health - March 22, 2018 Category: Consumer Health News Authors: Teresa Cutter — The Healthy Chef Tags: Uncategorized Cooking Food healthytime Recipes weekend recipe Source Type: news

Mass. Eye & Ear makes history with first gene therapy procedure for inherited blindness
Photo courtesy of Mass. Eye & Ear Massachusetts Eye and Ear Infirmary made history this week, becoming the first institution to use an FDA-approved gene therapy to treat a patient with an inherited disease. Spark Therapeutics‘ (NSDQ:ONCE) Luxturna gene therapy, which was approved by the FDA in December, is designed to improve vision in patients with inherited retinal disease caused by a particular genetic mutation. Yesterday, Dr. Jason Comander injected the treatment into the eye of a 13-year-old boy from New Jersey. Get the full story at our sister site, Drug Delivery Business News. The post Mass. Eye & Ear ...
Source: Mass Device - March 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Optical/Ophthalmic Pharmaceuticals Wall Street Beat Massachusetts Eye & Ear Infirmary sparktherapeutics Source Type: news

Children's Hospital Los Angeles treats first patient on the west coast using gene therapy
(Children's Hospital Los Angeles) Surgeons of The Vision Center at Children's Hospital Los Angeles completed a revolutionary gene replacement procedure on Tuesday, March 20 at 9:20 AM, to restore vision in a patient with retinal degeneration, using the first gene therapy ever approved for a genetic condition in the United States. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Mass. Eye and Ear makes history, injecting $850,000 gene therapy for first time
Philadelphia-based biotech Spark Therapeutics made history in December by winning FDA approval for the first gene therapy for an inherited disease. Now, Massachusetts Eye and Ear says it has performed the first post-approval injection of the drug, which treats a form of blindness and costs $850,000. The hospital announced on Tuesday that Jason Comander, the associate director of its inherited retinal disorders service, had performed the procedure on a 13-year-old boy from New Jersey. He is the first… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2018 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Mass. Eye and Ear makes history, injecting $850,000 gene therapy for first time
Philadelphia-based biotech Spark Therapeutics made history in December by winning FDA approval for the first gene therapy for an inherited disease. Now, Massachusetts Eye and Ear says it has performed the first post-approval injection of the drug, which treats a form of blindness and costs $850,000. The hospital announced on Tuesday that Jason Comander, the associate director of its inherited retinal disorders service, had performed the procedure on a 13-year-old boy from New Jersey. He is the first… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 20, 2018 Category: Biotechnology Authors: Max Stendahl Source Type: news

Patients regain sight after receiving engineered retinal tissue
The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration have regained reading vision. (Source: Medical Research Council General News)
Source: Medical Research Council General News - March 20, 2018 Category: Research Source Type: news

Retinal patch with stem cells treats macular degeneraiton
Researchers in California have developed a retinal patch with stem cells to improve the vision of people with age-related macular degeneration. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 19, 2018 Category: Consumer Health News Source Type: news

Stem cells treat macular degeneration
In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close. A few months later, he became part of a clinical trial that used stem cell-derived ocular cells developed in part by researchers at UC Santa Barbara. His retinal eyepatch was implanted at Moorfields Eye Hospital, a National Health Service (NHS) facility in Waters' hometown of London, England. (Source: World Pharma News)
Source: World Pharma News - March 19, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Stem cells treat macular degeneration
(University of California - Santa Barbara) UCSB researchers helped develop a specially engineered retinal patch to treat people with sudden, severe sight loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2018 Category: International Medicine & Public Health Source Type: news

Google researchers find trained AI detects diabetic retinopathy on par with experts
 In new study published in Ophthalmology,  Google AI researchers found that they could improve their AI disease detecting software by using a small subset of images adjudicated by ophthalmologists that specialize in retinal diseases. (Source: mobihealthnews)
Source: mobihealthnews - March 14, 2018 Category: Information Technology Source Type: news

Diabetes type 2 diet: Eating more of this green vegetable can help lower blood sugar
DIABETES TYPE 2 symptoms, if they are ignored, can lead to several health complications. But the best way to manage the condition is to exercise regularly and eat a healthy diet. Certain foods have been proven to help lower blood sugar levels, including a particular leafy green vegetable, high in magnesium and vitamin A. (Source: Daily Express - Health)
Source: Daily Express - Health - March 13, 2018 Category: Consumer Health News Source Type: news

Diabetes type 2 diet: Eating this leafy green vegetable can help to lower blood sugar
DIABETES TYPE 2 symptoms, if they are ignored, can lead to several health complications. But the best way to manage the condition is to exercise regularly and eat a healthy diet. Certain foods have been proven to help lower blood sugar levels, including a particular leafy green vegetable, high in magnesium and vitamin A. (Source: Daily Express - Health)
Source: Daily Express - Health - March 13, 2018 Category: Consumer Health News Source Type: news

Diabetes type 2 diet: Eating this leafy green vegetable can help lower blood sugar
DIABETES TYPE 2 symptoms, if they are ignored, can lead to several health complications. But the best way to manage the condition is to exercise regularly and eat a healthy diet. Certain foods have been proven to help lower blood sugar levels, including a particular leafy green vegetable, high in magnesium and vitamin A. (Source: Daily Express - Health)
Source: Daily Express - Health - March 13, 2018 Category: Consumer Health News Source Type: news